These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34123613)

  • 1. Review on Pneumococcal Infection in Children.
    Thadchanamoorthy V; Dayasiri K
    Cureus; 2021 May; 13(5):e14913. PubMed ID: 34123613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory Effects of Pneumococcal Extracellular Vesicles on Cellular and Humoral Host Defenses.
    Codemo M; Muschiol S; Iovino F; Nannapaneni P; Plant L; Wai SN; Henriques-Normark B
    mBio; 2018 Apr; 9(2):. PubMed ID: 29636428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal vaccines. WHO position paper.
    Wkly Epidemiol Rec; 1999 Jun; 74(23):177-83. PubMed ID: 10437429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pneumococcal conjugate vaccine.
    Jacobson RM; Poland GA
    Minerva Pediatr; 2002 Aug; 54(4):295-303. PubMed ID: 12131865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pneumococcal infections in children with asplenia.
    Schutze GE; Mason EO; Barson WJ; Kim KS; Wald ER; Givner LB; Tan TQ; Bradley JS; Yogev R; Kaplan SL
    Pediatr Infect Dis J; 2002 Apr; 21(4):278-82. PubMed ID: 12075756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of pneumococcal vaccination in infants and young children].
    Adam D; Scholz H
    Klin Padiatr; 2001; 213(3):109-13. PubMed ID: 11417363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum antibodies to pneumolysin with those to pneumococcal capsular polysaccharides in children with acute otitis media.
    Virolainen A; Jero J; Chattopadhyay P; Karma P; Eskola J; Leinonen M
    Pediatr Infect Dis J; 1996 Feb; 15(2):128-33. PubMed ID: 8822285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus pneumoniae infections in the neonate.
    Hoffman JA; Mason EO; Schutze GE; Tan TQ; Barson WJ; Givner LB; Wald ER; Bradley JS; Yogev R; Kaplan SL
    Pediatrics; 2003 Nov; 112(5):1095-102. PubMed ID: 14595052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
    Cockeran R; Anderson R; Feldman C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Infections and Invasive Potential of Nonencapsulated
    Bradshaw JL; Pipkins HR; Keller LE; Pendarvis JK; McDaniel LS
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
    Weycker D; Richardson E; Oster G
    Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children.
    Xu Q; Casey JR; Almudevar A; Pichichero ME
    Clin Microbiol Infect; 2017 Jul; 23(7):487.e1-487.e6. PubMed ID: 28143785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologically indicated pneumococcal respiratory infection in children.
    Korppi M; Koskela M; Jalonen E; Leinonen M
    Scand J Infect Dis; 1992; 24(4):437-43. PubMed ID: 1411309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Invasive pneumococcal disease in Poland in 2010].
    Skoczyńska A; Kuch A; Gołebiewska A; Waśko I; Ronkiewicz P; Markowska M; Hryniewicz W
    Pol Merkur Lekarski; 2011 Aug; 31(182):80-5. PubMed ID: 21936342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.